Active	Status	Sponsor type	Region	Phase	Filter
15 Active 4 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Meziani, Ferhat
REITAB-2, NCT05204563: Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, )	Recruiting	3	450	Europe, US, RoW	Combination of Imipenem/Cilastatin and XNW4107, Imipenem/Cilastatin/Relebactam, Recarbrio	Evopoint Biosciences Inc.	Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia	04/25	12/25
NCT05962606: Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.	Recruiting	2	100	Europe	AON-D21, Placebo	Aptarion Biotech AG	Community-acquired Pneumonia	05/25	06/25
RESCUE3, NCT03783884: A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation	Terminated	N/A	223	Europe, US	Lungpacer Diaphragm Pacing Therapy, Lungpacer DPTS, AeroPace System	Lungpacer Medical Inc.	Ventilator Induced Diaphragm Dysfunction	12/22	01/23
Siami, Shidasp
No trials found
DECHANET, Aline
No trials found